Skip to content
2000
Volume 17, Issue 2
  • ISSN: 1573-3963
  • E-ISSN: 1875-6336

Abstract

Critical congenital heart defects (CCHDs) are serious malformations that remain to be an important cause of neonatal mortality and morbidity. The clinical presentations of CCHD are shock, cyanosis, or respiratory distress, which may be similar to that of other neonatal conditions. Failure to diagnose these conditions early on after birth may result in acute cardiovascular collapse and death. Screening with routine pulse oximetry is efficient in distinguishing newborns with CCHD and other hypoxemic illnesses, which may otherwise be potentially life-threatening. If the cardiovascular system cannot be observed by echocardiography, then treatment with continuous prostaglandin-E1(PGE1) infusion should be started in any newborn whose condition deteriorates in the first few days of life. This review aims to provide a concise summary of the presentation and management of various CCHDs and to emphasize the role of timely diagnosis in the management.

Loading

Article metrics loading...

/content/journals/cpr/10.2174/1573396317666210219162515
2021-05-01
2025-05-19
Loading full text...

Full text loading...

/content/journals/cpr/10.2174/1573396317666210219162515
Loading

  • Article Type:
    Review Article
Keyword(s): congenital; Critical; ductus arteriosus; heart disease; neonate; prostaglandin-E1
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test